Global Oral Cholera Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Oral Cholera Vaccine Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Shanchol
1.2.3 Dukoral
1.2.4 Vaxchora
1.2.5 Others
1.3 Market Segment by Application
1.3.1 Global Oral Cholera Vaccine Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital
1.3.3 Research & Academic Laboratories
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Oral Cholera Vaccine Market Size (2017-2028)
2.1.1 Global Oral Cholera Vaccine Revenue (2017-2028)
2.1.2 Global Oral Cholera Vaccine Sales (2017-2028)
2.2 Global Oral Cholera Vaccine Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Oral Cholera Vaccine Sales by Regions (2017-2022)
2.2.2 Global Oral Cholera Vaccine Revenue by Regions (2017-2022)
2.3 Global Oral Cholera Vaccine Market Size Forecast by Region
2.3.1 Global Oral Cholera Vaccine Sales Forecast by Region (2023-2028)
2.3.2 Global Oral Cholera Vaccine Revenue Forecast by Region (2023-2028)
2.4 Global Top Oral Cholera Vaccine Regions (Countries) Ranking by Market Size
2.5 Oral Cholera Vaccine Market Dynamics
2.5.1 Oral Cholera Vaccine Market Trends
2.5.2 Oral Cholera Vaccine Market Drivers
2.5.3 Oral Cholera Vaccine Market Challenges
2.5.4 Oral Cholera Vaccine Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Oral Cholera Vaccine Manufacturers by Sales (2017-2022)
3.1.1 Global Oral Cholera Vaccine Sales by Manufacturers (2017-2022)
3.1.2 Global Oral Cholera Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Oral Cholera Vaccine Sales in 2021
3.2 Global Top Manufacturers Oral Cholera Vaccine by Revenue
3.2.1 Global Oral Cholera Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Top Oral Cholera Vaccine Manufacturers Covered: Ranking by Revenue
3.2.3 Global Oral Cholera Vaccine Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Oral Cholera Vaccine Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Cholera Vaccine as of 2021)
3.4 Global Oral Cholera Vaccine Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Oral Cholera Vaccine Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Oral Cholera Vaccine Market
3.7 Key Manufacturers Oral Cholera Vaccine Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Oral Cholera Vaccine Market Size by Type
4.1 Global Oral Cholera Vaccine Historic Market Review by Type (2017-2022)
4.1.1 Global Oral Cholera Vaccine Sales Market Share by Type (2017-2022)
4.1.2 Global Oral Cholera Vaccine Revenue Market Share by Type (2017-2022)
4.1.3 Oral Cholera Vaccine Price by Type (2017-2022)
4.2 Global Oral Cholera Vaccine Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Oral Cholera Vaccine Sales Forecast by Type (2023-2028)
4.2.2 Global Oral Cholera Vaccine Revenue Forecast by Type (2023-2028)
4.2.3 Oral Cholera Vaccine Price Forecast by Type (2023-2028)
5 Global Oral Cholera Vaccine Market Size by Application
5.1 Global Oral Cholera Vaccine Historic Market Review by Application (2017-2022)
5.1.1 Global Oral Cholera Vaccine Sales Market Share by Application (2017-2022)
5.1.2 Global Oral Cholera Vaccine Revenue Market Share by Application (2017-2022)
5.1.3 Oral Cholera Vaccine Price by Application (2017-2022)
5.2 Global Oral Cholera Vaccine Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Oral Cholera Vaccine Sales Forecast by Application (2023-2028)
5.2.2 Global Oral Cholera Vaccine Revenue Forecast by Application (2023-2028)
5.2.3 Oral Cholera Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Oral Cholera Vaccine Sales Breakdown by Company
6.1.1 North America Oral Cholera Vaccine Sales by Company (2017-2022)
6.1.2 North America Oral Cholera Vaccine Revenue by Company (2017-2022)
6.2 North America Oral Cholera Vaccine Market Size by Type
6.2.1 North America Oral Cholera Vaccine Sales by Type (2017-2028)
6.2.2 North America Oral Cholera Vaccine Revenue by Type (2017-2028)
6.3 North America Oral Cholera Vaccine Market Size by Application
6.3.1 North America Oral Cholera Vaccine Sales by Application (2017-2028)
6.3.2 North America Oral Cholera Vaccine Revenue by Application (2017-2028)
6.4 North America Oral Cholera Vaccine Market Size by Country
6.4.1 North America Oral Cholera Vaccine Sales by Country (2017-2028)
6.4.2 North America Oral Cholera Vaccine Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Oral Cholera Vaccine Sales Breakdown by Company
7.1.1 Europe Oral Cholera Vaccine Sales by Company (2017-2022)
7.1.2 Europe Oral Cholera Vaccine Revenue by Company (2017-2022)
7.2 Europe Oral Cholera Vaccine Market Size by Type
7.2.1 Europe Oral Cholera Vaccine Sales by Type (2017-2028)
7.2.2 Europe Oral Cholera Vaccine Revenue by Type (2017-2028)
7.3 Europe Oral Cholera Vaccine Market Size by Application
7.3.1 Europe Oral Cholera Vaccine Sales by Application (2017-2028)
7.3.2 Europe Oral Cholera Vaccine Revenue by Application (2017-2028)
7.4 Europe Oral Cholera Vaccine Market Size by Country
7.4.1 Europe Oral Cholera Vaccine Sales by Country (2017-2028)
7.4.2 Europe Oral Cholera Vaccine Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oral Cholera Vaccine Sales Breakdown by Company
8.1.1 Asia Pacific Oral Cholera Vaccine Sales by Company (2017-2022)
8.1.2 Asia Pacific Oral Cholera Vaccine Revenue by Company (2017-2022)
8.2 Asia Pacific Oral Cholera Vaccine Market Size by Type
8.2.1 Asia Pacific Oral Cholera Vaccine Sales by Type (2017-2028)
8.2.2 Asia Pacific Oral Cholera Vaccine Revenue by Type (2017-2028)
8.3 Asia Pacific Oral Cholera Vaccine Market Size by Application
8.3.1 Asia Pacific Oral Cholera Vaccine Sales by Application (2017-2028)
8.3.2 Asia Pacific Oral Cholera Vaccine Revenue by Application (2017-2028)
8.4 Asia Pacific Oral Cholera Vaccine Market Size by Region
8.4.1 Asia Pacific Oral Cholera Vaccine Sales by Region
8.4.2 Asia Pacific Oral Cholera Vaccine Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America Oral Cholera Vaccine Sales Breakdown by Company
9.1.1 Latin America Oral Cholera Vaccine Sales by Company (2017-2022)
9.1.2 Latin America Oral Cholera Vaccine Revenue by Company (2017-2022)
9.2 Latin America Oral Cholera Vaccine Market Size by Type
9.2.1 Latin America Oral Cholera Vaccine Sales by Type (2017-2028)
9.2.2 Latin America Oral Cholera Vaccine Revenue by Type (2017-2028)
9.3 Latin America Oral Cholera Vaccine Market Size by Application
9.3.1 Latin America Oral Cholera Vaccine Sales by Application (2017-2028)
9.3.2 Latin America Oral Cholera Vaccine Revenue by Application (2017-2028)
9.4 Latin America Oral Cholera Vaccine Market Size by Country
9.4.1 Latin America Oral Cholera Vaccine Sales by Country (2017-2028)
9.4.2 Latin America Oral Cholera Vaccine Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Oral Cholera Vaccine Sales Breakdown by Company
10.1.1 Middle East and Africa Oral Cholera Vaccine Sales by Company (2017-2022)
10.1.2 Middle East and Africa Oral Cholera Vaccine Revenue by Company (2017-2022)
10.2 Middle East and Africa Oral Cholera Vaccine Market Size by Type
10.2.1 Middle East and Africa Oral Cholera Vaccine Sales by Type (2017-2028)
10.2.2 Middle East and Africa Oral Cholera Vaccine Revenue by Type (2017-2028)
10.3 Middle East and Africa Oral Cholera Vaccine Market Size by Application
10.3.1 Middle East and Africa Oral Cholera Vaccine Sales by Application (2017-2028)
10.3.2 Middle East and Africa Oral Cholera Vaccine Revenue by Application (2017-2028)
10.4 Middle East and Africa Oral Cholera Vaccine Market Size by Country
10.4.1 Middle East and Africa Oral Cholera Vaccine Sales by Country (2017-2028)
10.4.2 Middle East and Africa Oral Cholera Vaccine Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 PaxVax
11.1.1 PaxVax Corporation Information
11.1.2 PaxVax Overview
11.1.3 PaxVax Oral Cholera Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 PaxVax Oral Cholera Vaccine Products and Services
11.1.5 PaxVax Oral Cholera Vaccine SWOT Analysis
11.1.6 PaxVax Recent Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Overview
11.2.3 Sanofi Oral Cholera Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Sanofi Oral Cholera Vaccine Products and Services
11.2.5 Sanofi Oral Cholera Vaccine SWOT Analysis
11.2.6 Sanofi Recent Developments
11.3 Valneva
11.3.1 Valneva Corporation Information
11.3.2 Valneva Overview
11.3.3 Valneva Oral Cholera Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Valneva Oral Cholera Vaccine Products and Services
11.3.5 Valneva Oral Cholera Vaccine SWOT Analysis
11.3.6 Valneva Recent Developments
11.4 EuBiologics
11.4.1 EuBiologics Corporation Information
11.4.2 EuBiologics Overview
11.4.3 EuBiologics Oral Cholera Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 EuBiologics Oral Cholera Vaccine Products and Services
11.4.5 EuBiologics Oral Cholera Vaccine SWOT Analysis
11.4.6 EuBiologics Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Oral Cholera Vaccine Value Chain Analysis
12.2 Oral Cholera Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oral Cholera Vaccine Production Mode & Process
12.4 Oral Cholera Vaccine Sales and Marketing
12.4.1 Oral Cholera Vaccine Sales Channels
12.4.2 Oral Cholera Vaccine Distributors
12.5 Oral Cholera Vaccine Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of TablesTable 1. Global Oral Cholera Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Shanchol
Table 3. Major Manufacturers of Dukoral
Table 4. Major Manufacturers of Vaxchora
Table 5. Major Manufacturers of Others
Table 6. Global Oral Cholera Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Oral Cholera Vaccine Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 8. Global Oral Cholera Vaccine Sales by Region (2017-2022) & (K Units)
Table 9. Global Oral Cholera Vaccine Sales Market Share by Region (2017-2022)
Table 10. Global Oral Cholera Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Oral Cholera Vaccine Revenue Market Share by Region (2017-2022)
Table 12. Global Oral Cholera Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 13. Global Oral Cholera Vaccine Sales Market Share Forecast by Region (2023-2028)
Table 14. Global Oral Cholera Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 15. Global Oral Cholera Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 16. Top Oral Cholera Vaccine Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 17. Oral Cholera Vaccine Market Trends
Table 18. Oral Cholera Vaccine Market Drivers
Table 19. Oral Cholera Vaccine Market Challenges
Table 20. Oral Cholera Vaccine Market Restraints
Table 21. Global Oral Cholera Vaccine Sales by Manufacturers (2017-2022) & (K Units)
Table 22. Global Oral Cholera Vaccine Sales Share by Manufacturers (2017-2022)
Table 23. Global Oral Cholera Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Ranking of Global Top Oral Cholera Vaccine Manufacturers by Revenue (US$ Million) in 2021
Table 25. Oral Cholera Vaccine Revenue Share by Manufacturers (2017-2022)
Table 26. Global Oral Cholera Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Cholera Vaccine as of 2021)
Table 28. Key Manufacturers Oral Cholera Vaccine Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 29. Key Manufacturers Oral Cholera Vaccine Plants/Factories Distribution
Table 30. Key Manufacturers Oral Cholera Vaccine Area Served
Table 31. Date of Key Manufacturers Enter into Oral Cholera Vaccine Market
Table 32. Key Manufacturers Oral Cholera Vaccine Product Type
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Oral Cholera Vaccine Sales (K Units) by Type (2017-2022)
Table 35. Global Oral Cholera Vaccine Sales Share by Type (2017-2022)
Table 36. Global Oral Cholera Vaccine Revenue (US$ Million) Market Share by Type (2017-2022)
Table 37. Global Oral Cholera Vaccine Price (K Units) by Type (2017-2022)
Table 38. Global Oral Cholera Vaccine Sales (K Units) by Type (2023-2028)
Table 39. Global Oral Cholera Vaccine Sales Share by Type (2023-2028)
Table 40. Global Oral Cholera Vaccine Revenue (US$ Million) Market Share by Type (2023-2028)
Table 41. Global Oral Cholera Vaccine Revenue Share by Type (2023-2028)
Table 42. Global Oral Cholera Vaccine Price (K Units) by Type (2023-2028)
Table 43. Global Oral Cholera Vaccine Sales (K Units) by Application (2017-2022)
Table 44. Global Oral Cholera Vaccine Sales Share by Application (2017-2022)
Table 45. Global Oral Cholera Vaccine Revenue (US$ Million) Market Share by Application (2017-2022)
Table 46. Global Oral Cholera Vaccine Price (K Units) by Application (2017-2022)
Table 47. Global Oral Cholera Vaccine Sales (K Units) by Application (2023-2028)
Table 48. Global Oral Cholera Vaccine Sales Share by Application (2023-2028)
Table 49. Global Oral Cholera Vaccine Revenue (US$ Million) Market Share by Application (2023-2028)
Table 50. Global Oral Cholera Vaccine Revenue Share by Application (2023-2028)
Table 51. Global Oral Cholera Vaccine Price (K Units) by Application (2023-2028)
Table 52. North America Oral Cholera Vaccine Sales by Company (2017-2022) & (K Units)
Table 53. North America Oral Cholera Vaccine Sales Market Share by Company (2017-2022)
Table 54. North America Oral Cholera Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 55. North America Oral Cholera Vaccine Revenue Market Share by Company (2017-2022)
Table 56. North America Oral Cholera Vaccine Sales by Type (2017-2022) & (K Units)
Table 57. North America Oral Cholera Vaccine Sales by Type (2023-2028) & (K Units)
Table 58. North America Oral Cholera Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 59. North America Oral Cholera Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 60. North America Oral Cholera Vaccine Sales by Application (2017-2022) & (K Units)
Table 61. North America Oral Cholera Vaccine Sales by Application (2023-2028) & (K Units)
Table 62. North America Oral Cholera Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 63. North America Oral Cholera Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 64. North America Oral Cholera Vaccine Sales by Country (2017-2022) & (K Units)
Table 65. North America Oral Cholera Vaccine Sales by Country (2023-2028) & (K Units)
Table 66. North America Oral Cholera Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 67. North America Oral Cholera Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 68. Europe Oral Cholera Vaccine Sales by Company (2017-2022) & (K Units)
Table 69. Europe Oral Cholera Vaccine Sales Market Share by Company (2017-2022)
Table 70. Europe Oral Cholera Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 71. Europe Oral Cholera Vaccine Revenue Market Share by Company (2017-2022)
Table 72. Europe Oral Cholera Vaccine Sales by Type (2017-2022) & (K Units)
Table 73. Europe Oral Cholera Vaccine Sales by Type (2023-2028) & (K Units)
Table 74. Europe Oral Cholera Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 75. Europe Oral Cholera Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 76. Europe Oral Cholera Vaccine Sales by Application (2017-2022) & (K Units)
Table 77. Europe Oral Cholera Vaccine Sales by Application (2023-2028) & (K Units)
Table 78. Europe Oral Cholera Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 79. Europe Oral Cholera Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 80. Europe Oral Cholera Vaccine Sales by Country (2017-2022) & (K Units)
Table 81. Europe Oral Cholera Vaccine Sales by Country (2023-2028) & (K Units)
Table 82. Europe Oral Cholera Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 83. Europe Oral Cholera Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 84. Asia Pacific Oral Cholera Vaccine Sales by Company (2017-2022) & (K Units)
Table 85. Asia Pacific Oral Cholera Vaccine Sales Market Share by Company (2017-2022)
Table 86. Asia Pacific Oral Cholera Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 87. Asia Pacific Oral Cholera Vaccine Revenue Market Share by Company (2017-2022)
Table 88. Asia Pacific Oral Cholera Vaccine Sales by Type (2017-2022) & (K Units)
Table 89. Asia Pacific Oral Cholera Vaccine Sales by Type (2023-2028) & (K Units)
Table 90. Asia Pacific Oral Cholera Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 91. Asia Pacific Oral Cholera Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 92. Asia Pacific Oral Cholera Vaccine Sales by Application (2017-2022) & (K Units)
Table 93. Asia Pacific Oral Cholera Vaccine Sales by Application (2023-2028) & (K Units)
Table 94. Asia Pacific Oral Cholera Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 95. Asia Pacific Oral Cholera Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 96. Asia Pacific Oral Cholera Vaccine Sales by Region (2017-2022) & (K Units)
Table 97. Asia Pacific Oral Cholera Vaccine Sales by Region (2023-2028) & (K Units)
Table 98. Asia Pacific Oral Cholera Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 99. Asia Pacific Oral Cholera Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 100. Latin America Oral Cholera Vaccine Sales by Company (2017-2022) & (K Units)
Table 101. Latin America Oral Cholera Vaccine Sales Market Share by Company (2017-2022)
Table 102. Latin America Oral Cholera Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 103. Latin America Oral Cholera Vaccine Revenue Market Share by Company (2017-2022)
Table 104. Latin America Oral Cholera Vaccine Sales by Type (2017-2022) & (K Units)
Table 105. Latin America Oral Cholera Vaccine Sales by Type (2023-2028) & (K Units)
Table 106. Latin America Oral Cholera Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 107. Latin America Oral Cholera Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 108. Latin America Oral Cholera Vaccine Sales by Application (2017-2022) & (K Units)
Table 109. Latin America Oral Cholera Vaccine Sales by Application (2023-2028) & (K Units)
Table 110. Latin America Oral Cholera Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 111. Latin America Oral Cholera Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 112. Latin America Oral Cholera Vaccine Sales by Country (2017-2022) & (K Units)
Table 113. Latin America Oral Cholera Vaccine Sales by Country (2023-2028) & (K Units)
Table 114. Latin America Oral Cholera Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 115. Latin America Oral Cholera Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 116. Middle East and Africa Oral Cholera Vaccine Sales by Company (2017-2022) & (K Units)
Table 117. Middle East and Africa Oral Cholera Vaccine Sales Market Share by Company (2017-2022)
Table 118. Middle East and Africa Oral Cholera Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 119. Middle East and Africa Oral Cholera Vaccine Revenue Market Share by Company (2017-2022)
Table 120. Middle East and Africa Oral Cholera Vaccine Sales by Type (2017-2022) & (K Units)
Table 121. Middle East and Africa Oral Cholera Vaccine Sales by Type (2023-2028) & (K Units)
Table 122. Middle East and Africa Oral Cholera Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 123. Middle East and Africa Oral Cholera Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 124. Middle East and Africa Oral Cholera Vaccine Sales by Application (2017-2022) & (K Units)
Table 125. Middle East and Africa Oral Cholera Vaccine Sales by Application (2023-2028) & (K Units)
Table 126. Middle East and Africa Oral Cholera Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 127. Middle East and Africa Oral Cholera Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 128. Middle East and Africa Oral Cholera Vaccine Sales by Country (2017-2022) & (K Units)
Table 129. Middle East and Africa Oral Cholera Vaccine Sales by Country (2023-2028) & (K Units)
Table 130. Middle East and Africa Oral Cholera Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 131. Middle East and Africa Oral Cholera Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 132. PaxVax Corporation Information
Table 133. PaxVax Description and Overview
Table 134. PaxVax Oral Cholera Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 135. PaxVax Oral Cholera Vaccine Product and Services
Table 136. PaxVax Oral Cholera Vaccine SWOT Analysis
Table 137. PaxVax Recent Developments
Table 138. Sanofi Corporation Information
Table 139. Sanofi Description and Overview
Table 140. Sanofi Oral Cholera Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 141. Sanofi Oral Cholera Vaccine Product and Services
Table 142. Sanofi Oral Cholera Vaccine SWOT Analysis
Table 143. Sanofi Recent Developments
Table 144. Valneva Corporation Information
Table 145. Valneva Description and Overview
Table 146. Valneva Oral Cholera Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 147. Valneva Oral Cholera Vaccine Product and Services
Table 148. Valneva Oral Cholera Vaccine SWOT Analysis
Table 149. Valneva Recent Developments
Table 150. EuBiologics Corporation Information
Table 151. EuBiologics Description and Overview
Table 152. EuBiologics Oral Cholera Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 153. EuBiologics Oral Cholera Vaccine Product and Services
Table 154. EuBiologics Oral Cholera Vaccine SWOT Analysis
Table 155. EuBiologics Recent Developments
Table 156. Key Raw Materials Lists
Table 157. Raw Materials Key Suppliers Lists
Table 158. Oral Cholera Vaccine Distributors List
Table 159. Oral Cholera Vaccine Customers List
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of FiguresFigure 1. Oral Cholera Vaccine Product Picture
Figure 2. Global Oral Cholera Vaccine Sales Market Share by Type in 2021 & 2028
Figure 3. Shanchol Product Picture
Figure 4. Dukoral Product Picture
Figure 5. Vaxchora Product Picture
Figure 6. Others Product Picture
Figure 7. Global Oral Cholera Vaccine Sales Market Share by Application in 2021 & 2028
Figure 8. Hospital Use Case
Figure 9. Research & Academic Laboratories Use Case
Figure 10. Pharmaceutical & Biotechnology Companies Use Case
Figure 11. Others Use Case
Figure 12. Oral Cholera Vaccine Report Years Considered
Figure 13. Global Oral Cholera Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Oral Cholera Vaccine Market Size 2017-2028 (US$ Million)
Figure 15. Global Oral Cholera Vaccine Sales (2017-2022) & (K Units)
Figure 16. Global Oral Cholera Vaccine Market Size Market Share by Region: 2021 VS 2028
Figure 17. Global Oral Cholera Vaccine Sales Market Share by Region (2017-2022)
Figure 18. Global Oral Cholera Vaccine Sales Market Share by Region in 2021
Figure 19. Global Oral Cholera Vaccine Revenue Market Share by Region in 2017 VS 2021
Figure 20. Global Oral Cholera Vaccine Sales Share by Manufacturers in 2021
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Cholera Vaccine Sales in 2021
Figure 22. Oral Cholera Vaccine Revenue Share by Manufacturers in 2021
Figure 23. Oral Cholera Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 24. Global Oral Cholera Vaccine Revenue Share by Type (2017-2022)
Figure 25. Global Oral Cholera Vaccine Revenue Growth Rate by Type in 2017 & 2021
Figure 26. Global Oral Cholera Vaccine Revenue Share by Application (2017-2022)
Figure 27. Global Oral Cholera Vaccine Revenue Growth Rate by Application in 2017 & 2021
Figure 28. North America Oral Cholera Vaccine Sales Market Share by Type (2017-2028)
Figure 29. North America Oral Cholera Vaccine Revenue Market Share by Type (2017-2028)
Figure 30. North America Oral Cholera Vaccine Sales Market Share by Application (2017-2028)
Figure 31. North America Oral Cholera Vaccine Revenue Market Share by Application (2017-2028)
Figure 32. North America Oral Cholera Vaccine Sales Share by Country (2017-2028)
Figure 33. North America Oral Cholera Vaccine Revenue Share by Country (2017-2028)
Figure 34. U.S. Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 35. Canada Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 36. Europe Oral Cholera Vaccine Sales Market Share by Type (2017-2028)
Figure 37. Europe Oral Cholera Vaccine Revenue Market Share by Type (2017-2028)
Figure 38. Europe Oral Cholera Vaccine Sales Market Share by Application (2017-2028)
Figure 39. Europe Oral Cholera Vaccine Revenue Market Share by Application (2017-2028)
Figure 40. Europe Oral Cholera Vaccine Sales Share by Country (2017-2028)
Figure 41. Europe Oral Cholera Vaccine Revenue Share by Country (2017-2028)
Figure 42. Germany Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 43. France Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 44. U.K. Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 45. Italy Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 46. Russia Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 47. Asia Pacific Oral Cholera Vaccine Sales Market Share by Type (2017-2028)
Figure 48. Asia Pacific Oral Cholera Vaccine Revenue Market Share by Type (2017-2028)
Figure 49. Asia Pacific Oral Cholera Vaccine Sales Market Share by Application (2017-2028)
Figure 50. Asia Pacific Oral Cholera Vaccine Revenue Market Share by Application (2017-2028)
Figure 51. Asia Pacific Oral Cholera Vaccine Sales Share by Region (2017-2028)
Figure 52. Asia Pacific Oral Cholera Vaccine Revenue Share by Region (2017-2028)
Figure 53. China Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 54. Japan Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 55. South Korea Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 56. India Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 57. Australia Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 58. China Taiwan Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 59. Indonesia Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 60. Thailand Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 61. Malaysia Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 62. Latin America Oral Cholera Vaccine Sales Market Share by Type (2017-2028)
Figure 63. Latin America Oral Cholera Vaccine Revenue Market Share by Type (2017-2028)
Figure 64. Latin America Oral Cholera Vaccine Sales Market Share by Application (2017-2028)
Figure 65. Latin America Oral Cholera Vaccine Revenue Market Share by Application (2017-2028)
Figure 66. Latin America Oral Cholera Vaccine Sales Share by Country (2017-2028)
Figure 67. Latin America Oral Cholera Vaccine Revenue Share by Country (2017-2028)
Figure 68. Mexico Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 69. Brazil Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 70. Argentina Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 71. Middle East and Africa Oral Cholera Vaccine Sales Market Share by Type (2017-2028)
Figure 72. Middle East and Africa Oral Cholera Vaccine Revenue Market Share by Type (2017-2028)
Figure 73. Middle East and Africa Oral Cholera Vaccine Sales Market Share by Application (2017-2028)
Figure 74. Middle East and Africa Oral Cholera Vaccine Revenue Market Share by Application (2017-2028)
Figure 75. Middle East and Africa Oral Cholera Vaccine Sales Share by Country (2017-2028)
Figure 76. Middle East and Africa Oral Cholera Vaccine Revenue Share by Country (2017-2028)
Figure 77. Turkey Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 78. Saudi Arabia Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 79. UAE Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 80. Oral Cholera Vaccine Value Chain
Figure 81. Oral Cholera Vaccine Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed